3
Registered trials
1
Recruiting
2
Unique sponsors
2
Unique IMPs
3
Commercial trials
Drug classes (ATC)
—
ATC code not specified
2
C
Cardiology (ATC C)
1
Mechanism of action (INN-stem analysis)
Monoclonal antibody (immune)
1 substance
Unknown / small molecule
1 substance
Phase III:
1
Phase I (Other):
2
Phase III
1 trial-
RecruitingCelldex Therapeutics Inc. CommercialBARZOLVOLIMAB; EPINEPHRINE
Phase I (Other)
2 trials-
EndedNoucor Health S.A. CommercialIMP not specified
-
EndedNoucor Health S.A. CommercialIMP not specified
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Noucor Health S.A. | Commercial | 2 | Phase I (Other) | 0 |
| Celldex Therapeutics Inc. | Commercial | 1 | Phase III | 1 |
New trials by year
2022
2
2026
1